In addition, anti-WNT2 antibodies could induce specific apoptosis in NSCLC by inhibiting WNT signaling (37), making anti-WNT2 monoclonal antibodies one of the strategies for treating lung cancer. Here, WNT2 is linked to non-small cell lung carcinoma.